UniProt ID | RL34_HUMAN | |
---|---|---|
UniProt AC | P49207 | |
Protein Name | 60S ribosomal protein L34 | |
Gene Name | RPL34 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 117 | |
Subcellular Localization | Cytoplasm, cytosol . Cytoplasm . Endoplasmic reticulum . Detected on cytosolic polysomes (PubMed:25957688). Detected in ribosomes that are associated with the rough endoplasmic reticulum (By similarity). | |
Protein Description | Component of the large ribosomal subunit.. | |
Protein Sequence | MVQRLTYRRRLSYNTASNKTRLSRTPGNRIVYLYTKKVGKAPKSACGVCPGRLRGVRAVRPKVLMRLSKTKKHVSRAYGGSMCAKCVRDRIKRAFLIEEQKIVVKVLKAQAQSQKAK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MVQRLTYRRRLSY --CCCHHHHHHHHCC | 19.71 | 23882029 | |
10 | Methylation | QRLTYRRRLSYNTAS CHHHHHHHHCCCCCC | 20.98 | 115492105 | |
12 | Phosphorylation | LTYRRRLSYNTASNK HHHHHHHCCCCCCCC | 17.96 | 22617229 | |
13 | Phosphorylation | TYRRRLSYNTASNKT HHHHHHCCCCCCCCE | 22.56 | 23927012 | |
13 | Nitration | TYRRRLSYNTASNKT HHHHHHCCCCCCCCE | 22.56 | - | |
15 | Phosphorylation | RRRLSYNTASNKTRL HHHHCCCCCCCCEEE | 24.19 | 23927012 | |
17 | Phosphorylation | RLSYNTASNKTRLSR HHCCCCCCCCEEECC | 36.50 | 23927012 | |
19 | Ubiquitination | SYNTASNKTRLSRTP CCCCCCCCEEECCCC | 32.31 | 21890473 | |
19 | Acetylation | SYNTASNKTRLSRTP CCCCCCCCEEECCCC | 32.31 | 25953088 | |
20 | Phosphorylation | YNTASNKTRLSRTPG CCCCCCCEEECCCCC | 40.88 | 27080861 | |
29 | Methylation | LSRTPGNRIVYLYTK ECCCCCCEEEEEEEC | 26.18 | 115492113 | |
32 | Phosphorylation | TPGNRIVYLYTKKVG CCCCEEEEEEECCCC | 7.51 | 28152594 | |
34 | Phosphorylation | GNRIVYLYTKKVGKA CCEEEEEEECCCCCC | 9.99 | 28152594 | |
35 | Phosphorylation | NRIVYLYTKKVGKAP CEEEEEEECCCCCCC | 23.07 | 28152594 | |
36 | Acetylation | RIVYLYTKKVGKAPK EEEEEEECCCCCCCH | 31.72 | 19608861 | |
36 | Ubiquitination | RIVYLYTKKVGKAPK EEEEEEECCCCCCCH | 31.72 | 21906983 | |
37 | Ubiquitination | IVYLYTKKVGKAPKS EEEEEECCCCCCCHH | 48.71 | - | |
37 | Acetylation | IVYLYTKKVGKAPKS EEEEEECCCCCCCHH | 48.71 | 12429849 | |
43 | 2-Hydroxyisobutyrylation | KKVGKAPKSACGVCP CCCCCCCHHHCCCCC | 56.39 | - | |
43 | Ubiquitination | KKVGKAPKSACGVCP CCCCCCCHHHCCCCC | 56.39 | - | |
43 | Acetylation | KKVGKAPKSACGVCP CCCCCCCHHHCCCCC | 56.39 | 26210075 | |
44 | Phosphorylation | KVGKAPKSACGVCPG CCCCCCHHHCCCCCC | 27.94 | 28102081 | |
62 | Acetylation | GVRAVRPKVLMRLSK CCCHHCHHHHHHHHH | 37.12 | 26051181 | |
62 | Ubiquitination | GVRAVRPKVLMRLSK CCCHHCHHHHHHHHH | 37.12 | 21890473 | |
68 | Phosphorylation | PKVLMRLSKTKKHVS HHHHHHHHHCCHHHH | 28.10 | 29514088 | |
70 | Phosphorylation | VLMRLSKTKKHVSRA HHHHHHHCCHHHHHH | 41.78 | - | |
76 | Methylation | KTKKHVSRAYGGSMC HCCHHHHHHHCCCHH | 30.64 | 18583643 | |
78 | Phosphorylation | KKHVSRAYGGSMCAK CHHHHHHHCCCHHHH | 22.40 | 28102081 | |
81 | Phosphorylation | VSRAYGGSMCAKCVR HHHHHCCCHHHHHHH | 13.31 | 28102081 | |
82 | Sulfoxidation | SRAYGGSMCAKCVRD HHHHCCCHHHHHHHH | 2.66 | 30846556 | |
85 | 2-Hydroxyisobutyrylation | YGGSMCAKCVRDRIK HCCCHHHHHHHHHHH | 28.47 | - | |
85 | Ubiquitination | YGGSMCAKCVRDRIK HCCCHHHHHHHHHHH | 28.47 | 21890473 | |
85 | Acetylation | YGGSMCAKCVRDRIK HCCCHHHHHHHHHHH | 28.47 | 25953088 | |
88 | Methylation | SMCAKCVRDRIKRAF CHHHHHHHHHHHHHH | 36.64 | 18583651 | |
101 | Acetylation | AFLIEEQKIVVKVLK HHCCCHHHHHHHHHH | 40.52 | 26051181 | |
101 | Ubiquitination | AFLIEEQKIVVKVLK HHCCCHHHHHHHHHH | 40.52 | 21890473 | |
105 | Acetylation | EEQKIVVKVLKAQAQ CHHHHHHHHHHHHHH | 30.84 | 25953088 | |
105 | Ubiquitination | EEQKIVVKVLKAQAQ CHHHHHHHHHHHHHH | 30.84 | 21890473 | |
105 | 2-Hydroxyisobutyrylation | EEQKIVVKVLKAQAQ CHHHHHHHHHHHHHH | 30.84 | - | |
105 | Malonylation | EEQKIVVKVLKAQAQ CHHHHHHHHHHHHHH | 30.84 | 32601280 | |
108 | Sumoylation | KIVVKVLKAQAQSQK HHHHHHHHHHHHHHH | 41.25 | 28112733 | |
108 | Acetylation | KIVVKVLKAQAQSQK HHHHHHHHHHHHHHH | 41.25 | 25953088 | |
108 | 2-Hydroxyisobutyrylation | KIVVKVLKAQAQSQK HHHHHHHHHHHHHHH | 41.25 | - | |
108 | Ubiquitination | KIVVKVLKAQAQSQK HHHHHHHHHHHHHHH | 41.25 | - | |
115 | Acetylation | KAQAQSQKAK----- HHHHHHHHCC----- | 64.49 | 19826731 | |
115 | Ubiquitination | KAQAQSQKAK----- HHHHHHHHCC----- | 64.49 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RL34_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL34_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL34_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-36, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND MASSSPECTROMETRY. |